Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The new method combining dermoscopy and Reflectance Confocal Microscopy is more effective for evaluating vitiligo.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Low-level laser therapy combined with NB-UVB is a safe and potentially effective treatment for stable vitiligo.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Type I interferons play a key role in the development of various skin diseases.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Several treatments are effective for pigmentary disorders like vitiligo and melasma.

Combining narrow-band ultraviolet B light and stem cell transplantation helps repigmentation in vitiligo by maintaining calcium balance in mice.

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

There is a significant need for better-validated quality of life tools in dermatology.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.